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ABSTRACT 
Background 
Nurses in a variety of roles are involved in the management of medicines for patients 
with diabetes. Nurse prescribing should help optimise these roles. Nurses in the 
United Kingdom have virtually the same independent prescribing rights as doctors. 
There is little or no evidence on the extent to which nurse supplementary prescribing 
is used, or the impact and activity of nurse supplementary prescribing for patients 
with diabetes.  
AIM 
To examine the prescribing practices of Nurse Supplementary Prescribing in diabetes.  
METHOD 
A random sample of 214 Nurse Supplementary Prescribers self-completed a written 
questionnaire. 
RESULTS 
The majority of nurses held an academic qualification at degree level or higher, had a 
wealth of clinical experience, worked full-time, were based in primary care and 
worked in general practice. The majority of nurses prescribed between 1 and 5 items a 
week. Oral anti-diabetic drugs, hypertension and lipid-regulating drugs and insulins 
were the products most often prescribed. Over 85% had undertaken specialist training 
in diabetes prior to undertaking the prescribing programme. 
 
CONCLUSION 
Supplementary prescribing provides a practical and useful framework within which to 
prescribe medicines for patients with diabetes and its associated complications. 
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Specialist diabetes training is a necessary pre-requisite for nurses prescribing in this 
area. It is evident that there is still a place for supplementary prescribing.  
 
IMPLICATIONS FOR CLINICAL PRACTICE 
 Recent legislative changes mean that nurses can now independently prescribe 
practically any drug. 
  Nurses in general practice appear to prescribe most frequently as a Nurse 
Supplementary Prescriber for patients with diabetes. 
 Nurse Supplementary Prescribers are likely to use this mode of prescribing to 
deliver medicines to patients with diabetes.  
 Over two thirds prescribe for common but serious complications of diabetes 
e.g. hypertension, hyperlipidemia and cardiovascular disease 
 
Key words:  nurse supplementary prescribing, diabetes.  
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INTRODUCTION 
Diabetes Mellitus (DM) is one of the most common chronic diseases in both western 
and developing countries. Approximately 194 million people (5%) of the worldwide 
population currently suffer from this condition (Audit Commission 2000). The care of 
people with diabetes is complex. A quarter of people living with this disease also 
experience three or more other long-term conditions (Audit Commission 2000). In 
addition to the personal effects of such co-morbidities, much of the five million 
pounds a day  spent in the United Kingdom (UK) by the National Health Service 
(NHS) on its treatment (DoH 2003a), could be reduced with good healthcare and good 
self-management (DoH 2003b). 
 
The emphasis placed on the role expansion of nurses (DoH 1999), the need for staff to 
work together to reduce waiting times and deliver modern patient-centred services 
(DoH 2000) has meant that nurses-led care is seen as one means  of improving health 
care provision. There is evidence that nurses have lead roles to play in the delivery of 
care in a number of areas, especially chronic diseases (Campbell 2004, McKee & 
Nolte 2004, Raftery et al. 2005, Courtenay & Carey 2006). It is evident, that nurses 
working in a variety of roles, are involved in the treatment management of patients 
with diabetes (Carey & Courtenay 2007). These roles have developed in recognition 
of the fact that access to health professionals, who are skilled in insulin therapy and 
the management of diabetes, is vital in order to reduce long term complications and 
improve bed states (National Institute of Health 2005). The role of the nurse in service 
delivery for diabetes patients is emphasised by the National Service Framework 
(NSF) for Diabetes (DoH 2003a) and the prescription of medicines by nurses should 
help optimise this role. 
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In the UK, appropriately qualified community nurses are able to assess, diagnose and 
prescribe independently from a limited list of medicines included in the Nurse 
Prescribers’ Formulary (NPF) for Community Practitioners. Nurse Independent 
Prescribers (NIP) (previously known as independent extended prescribers) are 
similarly able to assess, diagnose and prescribe any licensed medicine (and some 
controlled drugs (CDs)) independently (DoH 2006). By contrast, Nurse 
Supplementary Prescribing (NSP) (DoH 2003b) takes place after an assessment and 
diagnosis of a patients condition has been made by a doctor, and a Clinical 
Management Plan (CMP) has been drawn up for the patient. The CMP includes a list 
of medicines from which the supplementary prescriber is able to prescribe (DoH 
2003b). Supplementary prescribers are able to prescribe any medicine (including 
unlicensed medicines and CDs), but, it is best suited to the management of chronic 
and long-term conditions such as DM. 
 
Training for Nurse Independent and Nurse Supplementary Prescribing is combined 
i.e. nurses successfully completing the prescribing programme are awarded the dual 
qualification of Nurse Independent/ Supplementary Prescriber (NISP).  Additionally 
nurses need to acquire specialist knowledge prior to undertake the prescribing 
programme (Nursing and Midwifery Council (NMC) 2006).  This knowledge may be 
attained in a number of ways e.g. university accredited modules or through 
experiential learning. There are now over 10,000 nurses across the UK able to 
prescribe both as NISPs (NMC 2007). 
 
Given the recent legislative changes surrounding the prescription of medicines by 
nurses it is important to evaluate the success or otherwise of these developments, and 
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also to identify key issues that are likely to arise. There is very little or no evidence of 
NSP and how this mode of prescribing is used to manage patients with diabetes. 
 
Background 
Three studies (Winocour et al. 2002, Craddock & Avery 1998, Courtenay et al. 2006) 
 provide evidence that nurses, caring for patients with diabetes, are involved  in 
medicines management. Winocour et al. (2002) surveyed 456 consultant physicians 
providing diabetes services across 238 acute NHS trusts and units.  It is unclear how 
many physicians returned the completed 92 item questionnaires, however, consultants 
providing services to over 75% of the trusts responded. Information collected from 
75% of the sample, indicated that diabetes specialist nurses (DSNs) were involved in 
adjusting medicines for hypoglycaemia. Additionally, respondents reported that over 
90% of these nurses had received training to educate patients and staff about diabetes. 
 
Specifically looking at the role DSNs play with regards to the practice of prescribing 
and adjusting insulin dose, Craddock and Avery (1998) distributed surveys in 1993 & 
1996 to 50 DSNs, in the South West Thames Region.  Of the 71 questionnaires 
distributed across the two surveys, over 70% of the nurses responded. Nurses 
completing the questionnaires in 1996 reported that they were less likely to consult 
doctors when changing the dose of insulin or changing the insulin regime. However, 
they were more likely to have agreed with the doctor the extent to which insulin dose 
could be altered. Additionally, participants in 1996 were more likely to adjust insulin 
dose over the telephone, dispense insulin from an agreed stock, use pre-signed 
prescriptions or supply patients with prescriptions with medical countersignatures. In 
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contrast to findings reported by Winocour et al. (2002), only 20% of these 
respondents reported that they had undergone any formal training in diabetes.  
 
Although not specifically focusing on diabetes, Courtenay et al. (2006) undertook a 
survey to provide a national perspective of independent extended/supplementary 
nurse prescribing practice. Respondents in this survey (n=868) were asked to identify 
the conditions for which they prescribed most frequently using supplementary 
prescribing. Diabetes was one of the most common conditions cited.   
 
As well as managing medicines for diabetes, there is evidence to suggest that nurses 
are effectively managing some of the common complications including hypertension, 
hyperlipidemia and cardiovascular disease (New et al. 2003, Denver et al. 2003). New 
et al. (2003) used a randomised controlled trial (RCT) (involving over 1500 patients) 
to examine the effect of specialist nurses on raised blood pressure, raised total 
cholesterol, and mortality. It was evident from the findings that a higher number of 
patients seen by the specialist nurse achieved their treatment targets and there was a 
significant reduction in patient mortality. Further support for these findings are 
provided by Denver et al. (2003).  Data collected from the 120 patients involved in 
this RCT identified that patients who attended the nurse-led clinic were three times 
more likely to reach a target systolic BP< 140 mmHg. Additionally these patients 
experienced a significant reduction in 10 year coronary heart disease and stroke risk 
scores.  
 
Although not specifically focusing on diabetes, size and make up of the practice 
population (Luker et al. 1997, Luker et al. 1998) and nurses’ role (Luker & McHugh 
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2002, While & Biggs 2004, Hall et al. 2006)  have been reported by researchers as  
factors influencing the low prescribing rates reported by District Nurses (DN) and 
Health Visitor (HV) prescribers. 
 
Three studies (Larsen 2004, Latter et al. 2005, Courtenay et al. 2006) have examined 
the prescribing patterns of independent extended nurse prescribers. In line with the 
low prescribing rates of DN/HV prescribers, Larsen (2004) in a survey of 307 nurse 
managers (working in accident and emergency departments, minor injury units, and 
walk-in-centres)  reports that only 27 out of 55 nurses who had undergone 
independent extended prescribing training were prescribing medicines.  
 
These findings are in contrast to those reported by Latter et al. (2005) and Courtenay 
et al. (2006). Over 90% of the 246 independent extended nurse prescribers surveyed 
by Latter et al. (2005) and nearly 90% of the 868 independent 
extended/supplementary prescribers surveyed by Courtenay et al. (2006) used 
independent prescribing. Interestingly, only 35% of the respondents in Courtenay et 
al.’s (2006) study reported that they had used supplementary prescribing.  
 
Restriction of local arrangements has recently been identified as a further factor that 
influences the prescription of medicines by nurses. Findings by Hall et al. (2006), 
involving the collection of semi structured interview data (from 23 HV and DN 
prescribers and 5 prescribing leads), and questionnaire data (from 44 DNs, HVs) 
across 3 Strategic Health Authorities,  identified that some nurses had to wait several 
months to receive their prescription pad and so were unable to prescribe once 
qualified. Nurses sampled by these researchers also identified a lack of access to the 
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patient’s medical records as a further barrier to prescribing. Additionally, the 
paperwork involved in writing a prescription, arranging delivery and issuing repeat 
supplies of an item, were identified by respondents as reasons to send the patient to 
the general practitioner for a prescription. Restrictions at a local level, including lack 
of prescribing pads, absence of prescribing budgets, and inability to computer 
generate prescription were also identified by Courtenay et al. (2006) and Latter et al. 
(2005) as factors which prevented the prescription of medicines by independent 
extended/supplementary prescribers.  
 
The evidence emerging from the literature indicates that medicines management is an 
area of care in which nurses, caring for patients with diabetes, are involved. These 
nurses are also managing the medicines for some of the common complications of this 
disease.  Evidence examining the rate at which nurses prescribe medicines is 
conflicting, and a number of factors have been reported as influencing the prescription 
of medicines by nurses. There is no evidence currently available specifically 
examining NSP for patients with diabetes. This is important given that diabetes has 
been identified as a condition for which NSPs prescribe most frequently.   
 
AIM 
The aim of the study was to provide a national evaluation of Nurse Independent and 
Nurse Supplementary Prescribing in diabetes in the UK. A key component was to 
examine the prescribing practices of nurses who use supplementary prescribing to 
prescribe medicines for patients with diabetes. This component forms the focus of this 
paper. 
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METHODOLOGY 
A survey design was used, with a postal questionnaire. The data were collected 
between October and December 2006. 
 
Sample 
The participants were 214 nurses located throughout the UK. All nurses were 
qualified NISPs and registered on the NMC data base. All prescribed medicines for 
patients with diabetes.   
 
One thousand nine hundred and ninety two nurses were selected at random from all 
(n=8000) nurses registered on the NMC database of NISPs i.e. 25% of all NIPs/NSPs 
across the UK. Based on the findings and response rate of previous national surveys 
undertaken by researchers (Courtenay et al. 2007, Latter et al. 2005), it was estimated 
that a 70% response rate would be achieved of whom 30% of respondents would 
prescribed medicines for patients with diabetes. This large sample was required to 
ensure that each one of the broad range of settings in which nurses prescribe 
medicines for people with diabetes is represented. After one follow up reminder 
questionnaire, 1400 (70%) questionnaires were returned, of which 1377 were 
completed. Twenty three were not completed as participants were no longer working 
in practice or were working abroad. Of the 1377 completed questionnaires, 439 
participants prescribed for diabetic patients and 214 used NSP. This paper reports on 
the findings for these 214 nurses.  
 
 
Questionnaire 
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Simple instructions with regards to how to complete the questions were provided on 
the first page of the booklet. The first section of the questionnaire collected some 
general demographic information. This included job title, participants Grade/Band 
(i.e. level of clinical expertise and band/grade in which the individual is placed and 
paid, band 5/E=low, band 9/I=high), whether they worked full time or part time, if 
they worked in primary and/or secondary care, their age, highest academic 
qualification, and prior to undertaking the prescribing programme, what if any 
specialist training they had undertaken. The sample were then asked to identify the 
length of time they had been qualified as a NISP, and how much experience they had 
acquired in their main area of practice before undertaking the prescribing programme. 
They were also asked to identify the methods they had used to deliver medicines to 
patients since they had qualified as a prescriber. 
  
Participants were then asked to list problems they had encountered that had hampered 
or prevented NSP in diabetes. Respondents were next asked to indicate what 
percentage of time each week they devoted to diabetes, and the number of items they 
prescribed as NSP in a typical week for patients with diabetes (i.e. 0, between 1 and 5, 
6 and 10, 11 and 20, 21 and 30, 31 and 40, 41 and 50, 51 plus), and which 
conditions/products they prescribed for these patients.  Tick boxes were supplied to 
indicate responses.  
 
Reliability and Validity  
A questionnaire booklet was developed for the purpose of the study. Its content was 
developed from previous work involving independent extended and supplementary 
nurse prescribers (Latter et al. 2005, Courtenay et al. 2006), a search of the literature 
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of nurse-led care in diabetes (Carey & Courtenay 2007) and the Nurse Prescribers 
Formulary (2005-2007) (BMA 2005). In order to pilot the questionnaire 20 qualified 
NISPs who prescribed for diabetic patients were asked to complete it. After doing so, 
they were asked to comment on its ease of completion, and if they experienced any 
difficulties understanding what was required of them at any point throughout the 
questionnaire. It was evident from the completed questionnaires that both the format 
and content of the questions were appropriate. Only minor refinements and 
amendments were made. Following data entry of the completed questionnaires ten 
percent were then reviewed by one of the authors (NC).  
 
Data collection  
Participants were sent a letter outlining the purpose of the study (and what would be 
required of them), an information sheet, and a copy of the questionnaire. The 
information sheet outlined the study aims, and what participants would be required to 
do. It also informed participants that the study was completely voluntary (and 
emphasised that individuals could withdraw at any point if they wished to do so), that 
responses were strictly confidential, that information collected from the questionnaire 
would be made anonymous, and that no identifying information would emanate from 
the research.  
Ethical approval 
A full research proposal was submitted for scrutiny by the Berkshire Research Ethics 
Committee and the University of Reading Ethics Committee. The study met the 
research governance criteria of these committees. Approval to undertake the study 
was therefore granted. Questionnaires were sent to the home address of participants. 
Return of a completed questionnaire was taken as consent to participate.  
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 Data analysis 
Microsoft Excel and SPSS version 14 were used for data entry and analysis. Chi 
Square tests were used to investigate how the number of items prescribed varied 
according to job title, age, specialist training in diabetes. Themes in qualitative data 
were identified, coded and analysed using content analysis. 
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RESULTS 
Demographic details 
The demographic data of the sample including job title, grade/band, part/full time 
work, area of work, age, academic qualification, time since qualified as NIP/NSP and 
years of experience in area of practice before undertaking the prescribing course are 
presented in Table 1.  
 
Specialist training 
One hundred and thirty seven (64.0%) indicated that they had undertaken a diploma, 
degree, and/ or masters level module prior to undertaking the prescribing programme. 
Ninety six (44.9%) had attended university accredited study days. Forty six (21.6%) 
had undergone informal training. This included visits to a specialist nurse or doctor 
working in a diabetes department, in-house training, and training provided by drug 
companies. Twenty nine (13.6%) had not undertaken any specialist training in 
diabetes. 
Problems hampering or preventing Nurse Supplementary Prescribing in 
diabetes 
Participants were asked to describe the problems they had encountered which were 
specific to diabetes prescribing. These problems were analysed using content analysis.  
Table 2  presents the categories that arose from this analysis. Sixty six responses were 
given.   Fifty nine percent (n=39) of NSPs who reported problems indicated that these 
were of a practical nature including access to and lack of a prescribing pad, inability 
to computer generate prescriptions, access to notes and communication. 
 
What proportion of your time each week is spent on diabetes? 
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Participants were asked to indicate what percentage of time each week they devoted 
to diabetes. One hundred and fifteen (54%) indicated that this was less than 20%. 
Fifty six (26%) reported this to be between 20-50%.  Thirty (14%) participants 
reported that more than 50% of their week was devoted to diabetes. 
 
In a typical week how many items do you supplementary prescribe for patients 
with diabetes?  
The number of items prescribed in a typical week as an NSP is presented in Table 3. 
Nearly thirty percent (n=46) of respondents prescribed between 1-5 items a week, 
however over 40% (n=63) prescribed more than 6 items a week.  Over 50% (n=50) of 
general practice nurses prescribed more than 6 items in a typical week. Thirty three 
percent of specialist nurses (n=10), 14% of senior nurses (n=1) and only 9% (n=2) of 
community nurses prescribed 6 or more items in a week. The differences between 
groups were statistically significant (p=0.001). However, neither age, nor the benefit 
of specialist training in diabetes, or confidence in diabetes prescribing had a 
significant effect on the number of items prescribed (p=0.871, p=0.279, p=0.218 
respectively).  
 
 
Conditions/Products prescribed by NSPs 
Table 4 describes the conditions/products that NSPs prescribe for diabetic patients. 
About 75% (n=106) of NSPs prescribe oral anti-diabetic drugs, while 66.0% (n=93) 
prescribe for hypertension and lipid regulating drugs, 64% (n=90) for cardiovascular 
disease and 56% (n=79) insulin’s.   
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Participants were asked to list the three things prescribed most often as a NSP for 
patients with diabetes. The most often listed were oral anti-diabetic drugs (66.9%), 
hypertension (47.9%), lipid regulating drugs (29.0%) and insulin’s (36.4%). General 
Practice nurses prescribed a significantly broader range of about 5 products, followed 
by specialist nurses (4 products/conditions) (p=0.031) (see Table 5).    
 
DISCUSSION 
Before summarising the key findings and drawing conclusions, a potential limitation 
of our study must be taken into account. Respondents were asked to report on the 
products they had prescribed along with the factors that had hampered of prevented 
prescribing in diabetes. It would have been helpful to have also asked respondents to 
indicate which products they had prescribed and the factors that had hampered or 
prevented prescribing in diabetes in the last 6 months. The majority of respondents 
had been qualified in excess of 2 years. Factors that had originally hampered or 
prevented prescribing may now not exist. Additionally, methods used within the last 6 
months may have differed from those used upon initial qualification. This additional 
data would have provided a fuller picture of current practice.  
 
The majority of nurses in our sample held an academic qualification at degree level or 
higher, had a wealth of clinical experience, work full-time, were based in primary care 
and worked in general practice. Nearly half the participants who prescribed for 
diabetes (48.7%) reported that they had prescribed using NSP.   
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These findings are consistent with those reported by Courtenay et al. (2006) and 
Latter et al. (2005). More than 80% of the nurses sampled in these two previous 
studies reported they used independent extended prescribing and that their highest 
academic qualification was at degree level of above. In comparison to previous 
findings, a greater number of nurses in our sample (over 65% compared to 39% 
reported by Latter et al. and 54% by Courtenay et al.) worked in general practice.   
 
Nearly 50% of the participants in our study reported that they used supplementary 
prescribing and 70% of these respondents reported that they prescribed between 1 and 
6 items a week. This is higher than that reported by Courtenay et al. (2006) who 
identified that just over a third of their sample used supplementary prescribing, the 
majority of respondents reporting that they prescribed less than 5 items a week for 
skin conditions. Respondents in our study also prescribed a greater number of items 
than DN/HV prescribers, these nurses frequently prescribing less than 1 item per 
week (Hall et al.  2006).    
 
In addition to prescribing drugs for diabetes, our findings show that over two thirds of 
respondents also prescribed for common complications of diabetes including 
hypertension, hyperlipidemia and cardiovascular disease.  These findings are in line 
with those reported by previous research (New et al. 2003, Denver et al. 2003). 
Hypertension, hyperlipidemia and cardiovascular disease are also areas in which 
nurses in these studies prescribed medicines. Our findings are also consistent with 
policy literature (DoH 2006, NMC 2006) where supplementary prescribing is 
described an ideal mechanism for the treatment of chronic long-term conditions.  
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The fact that NSP was used to prescribe a broader range of products  by  nurses in 
general practice, (the majority of whom also devoted less than 20% of their week to 
diabetes), perhaps provides some evidence that supplementary prescribing is a useful 
mechanism  to treat patients with multiple pathologies, where a team approach to care 
is necessary. Such nurses may only feel confident to prescribe for these conditions 
when using a CMP (NMC 2006).   
Over 85% of participants in our study reported that they had undertaken specialist 
training in diabetes (i.e. a diploma, degree, or masters level module in diabetes or 
accredited study days) prior to undertaking the prescribing programme.  This finding 
is consistent with those reported by Winocour et al. (2002) who reported that nearly 
all DSNs in their research had received training to educate patients and staff about 
diabetes. It is interesting to note that the NMC prescribing guidelines (NMC 2006).  
The NMC guidelines stipulate that nurses need to acquire specialist knowledge prior 
to undertaking the prescribing programme  (NMC 2006),  however, 14% of our 
sample had not undertaken any specialist training in diabetes.  
 
Participants in our sample reported a number of factors hampering or preventing 
supplementary prescribing in diabetes. Practical problems, (including access to and 
lack of prescribing pad, inability to computer generate prescriptions, access to notes 
and communication) were the most frequently cited by 18% (n= 39) of nurses. Lack 
of clinical knowledge, and competence were cited by 8.4% (n=18) of the sample. This 
is in line with Courtenay et al.  (2006) who reported that nearly 20% of the nurses in 
their study had experienced similar practical problems implementing prescribing.  
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Although the software to computer generate prescriptions in now available, and 
restriction of local arrangements may have been resolved shortly after the nurses in 
our sample had qualified, such restrictions have been identified as a barrier to 
prescribing by other researchers (Latter et al. 2005, Courtenay et al. 2006, Hall et al. 
2006). These are areas that warrant further exploration. The fact that nurses reported 
that clinical knowledge had prevented them prescribing, confirms that these nurses are 
aware they must only prescribe within their scope of practice and competence (NMC 
2006). This is reassuring bearing in mind that nurses now have practically the same 
prescribing rights as doctors.   
 
Despite the evidence that there have been implementation problems surrounding  
supplementary prescribing, and nurses are now able to independently prescribe 
practically any licensed medicine, our findings indicate NSPs are likely to use this 
mode of prescribing to deliver medicines to patients with diabetes.  
 
CONCLUSION 
Our findings suggest that modern patient-centred services are supported by the 
effective use of supplementary prescribing by nurses who prescribe for patients with 
diabetes.  As nurses are working in a variety of roles are involved in the care of 
patients with diabetes, our findings may be of interest to policy makers, practitioners 
and educationalists involved in this area of practice.  It is evident that there is still a 
place for supplementary prescribing. 
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TABLES 
Table 1: Demographic characteristics 
             n=number of 
responses 
% of total 
sample 
Job Title  
General practice   
(practice nurses and nurse practitioners) 
141 66.4 
Specialist nurses   
(clinical nurse specialists, specialist nurse practitioners, nurse 
clinicians, children’s nurses and midwives) 
33 15.4 
Community Nurses  
(community/modern matron, HV, DN, community children’s nurse 
specialist, community psychiatric nurses and learning disabilities) 
26 12.1 
Senior Nurses  
(nurse consultants, senior nurses, charge nurses, sisters, 
manager) 
12 5.6 
Grade/Band  
Grade F/G or Band 6 51 23.8 
Grade H or Band 7 101 44.4 
Grade I or Band 8/9 or Nurse Partner  46 21.5 
Part time/full time  
<20 hrs per week 18 8.4 
21-30 per week 76 35.5 
Full time i.e. >30 hrs per week 118 55 
Primary/and or Secondary Care  
Primary care 177 82.7 
Secondary Care 21 9.8 
Primary and Secondary Care 15 7.0 
Age   
<35 years  15 7.0 
36-45 years 83 38.8 
46-55 years 89 41.6 
55-65 years 26 12.1 
Academic Qualification   
Certificate level 4 1.9 
Diploma level 31 14.5 
Degree level 128 59.8 
Master level 48 22.4 
PhD. 3 1.4 
Time since Qualified as NIP/NSP   
< 6 months 3 1.4 
6-12 months 20 9.3 
1-2 years 73 34.1 
> 2 years 114 53.3 
Experience in area of practice before NIP/NSP   
< 1 year 3 1.4 
1-2 years 8 3.7 
2-5 years 26 12.1 
> 5 years 175 5 
Percents do not add to 100%  in each category as some participants 
 did not complete every question 
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Table 2.  Problems faced by Nurse Supplementary Prescribers with respect to     
prescribing in diabetes 
 
Problems as an NSP for diabetic prescribing Number of 
responses 
Percentage 
Practical problems, e.g. lack of resources 39 59.1% 
Lack of clinical knowledge, competence, patient 
compliance 
18 27.3% 
Employer restriction/objections by pharmacist, etc 16 24.2% 
Total  number of responses 66  
                  Note:  Percents do not add to 100% since respondents have generally more than one problem 
 
Table 3.  Number of items prescribed using Nurse Supplementary Prescribing in a  
    typical week to diabetic patients 
 
No of Items Frequency Percent 
0 47 30.1 
1 – 5 46 29.5 
6 – 10 31 19.9 
11 – 20 23 14.7 
> 20 9 5.8 
Total 156 100.0 
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Table 4.  Conditions/Products being prescribed using Nurse Supplementary   
    Prescribing for people with diabetes 
 
Conditions/Products 
NSP (n=141) 
 Frequency Percent 
Oral anti-diabetic drugs 106 75.2 
Hypertension 93 66.0 
Lipid regulating drugs 93 66.0 
Cardiovascular disease 90 63.8 
Insulin’s 79 56.0 
Management of micro-albuminuria 64 45.4 
Insulin pens, syringes and needles 62 44.0 
Obesity 61 43.3 
Monitoring (glucose, etc.) 59 41.8 
Hypoglycaemia 55 39.0 
Diabetic neuropathy (including erectile dysfunction) 43 30.5 
Fungal skin infection 39 27.7 
Smoking cessation 39 27.7 
Varicose eczema –atopic/contact dermatitis 38 27.0 
Immunisation – flu/pneumonia 37 26.2 
Leg or foot ulcers (chronic skin)  29 20.6 
Diabetic ketoacidosis 26 18.4 
Note:  Percents do not add to 100% since respondents have generally prescribed more than one product. 
 
 
Table 5.  Mean number of conditions/products prescribed as a Nurse Supplementary Prescriber 
 according to job title 
 
Job title categories Mean Std. Error 95% Confidence Interval 
    
Lower  
Bound Upper Bound 
General Practice 5.2 .413 4.393 6.021 
Specialist Nurses  3.9 .864 2.172 5.578 
Community Nurse 2.8 .958 0.957 4.736 
Senior 
Nurses/Managers 
2.0 1.545 -1.047 5.047 
 
 
 
 
 
